🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

🚨 We’re hiring! 🚨 Join the Bullman Lab at MD Anderson’s James P. Allison Institute as a Postdoctoral Fellow! ☀️ 📍Houston, TX Interested in advancing research on tumor microbes, cancer cell biology, & the TME? Reach out 📩 : [email protected] 🔗: jobs.mdanderson.org/Search/JobDeta…

Congrats Tuomas Tammela lab, Xueqian Zhuang, et al., on a beautiful study and a bit of silver lining re aging & cancer! This raises a fascinating concept that mutagenic carcinogens are key risk factors of youth, but those that promote inflammation may be key in our golden years.

iFlpMosaics are now published Nature Methods. A compendium of novel genetic tools and related methods for inducing and analysing genetic mosaics in a high-throughput manner. nature.com/articles/s4159… Tweetorial 👇

Happy to report the posting of a new study on compounds that block the interaction of RAS proteins with PI 3-kinase PIK3CA from Vividion Therapeutics @VividionTx, in collaboration with Francis Crick Institute Julian Downward biorxiv.org/content/10.110…

Excited to share a major breakthrough from the lab! D&D-seq is a new technology that bridges a key gap in single-cell multi-omics/genomics : the ability to map DNA:Protein (e.g., TFs or chromatin remodellers). Led by Ivan Raimondi, Wei-Yu Chi and Sang-Ho Yoon

Excited to announce my next chapter: I'm joining @UTSWNews as the inaugural Director of the Center for Cellular Therapies and Cancer Immunology! Looking forward to building innovative #immunotherapy programs and advancing #cancerresearch with the outstanding team at UTSW. #1/3

Excited to share our review that’s now out in Science Immunology. We describe how DC-T cell interactions in lymph nodes specify CD8+ T cell fates and sustain anti-tumour immune responses. Stefani Spranger Koch Institute at MIT | science.org/doi/10.1126/sc…

How does cancer immunotherapy work, and who are the best candidates? New research from CSHL and Massachusetts Institute of Technology (MIT) gives us some insight into the possible effectiveness of this treatment. cshl.edu/videos/is-canc…

Was fantastic presenting at a joint session of Cold Spring Harbor Laboratory and Northwell Health with Sepideh Gholami, MD, MAS, FACS, FSSO and Peter Westcott on a topic that needs more forward progress; Colorectal Cancer Liver Metastases. Looking forward to future collaborations!

Wrapping up our final day at #AMC25! Four days of insightful discussions, collaboration, & cutting-edge research. Grateful to everyone who joined us in DR🇩🇴to share insights, engage in conversations & foster collaborations. Until next time!🐭☀️🌴

Francis Collins resigned from NIH yesterday. He rightly pointed out that it's Human Genome Project revolutionized every aspect of biomedical research. He points out that NIH has historically been sens as high priority and non partisan. 1/

"It is critically important that we raise our voices in support of innovative cancer science and medicine." AACR President Lillian L. Siu Patricia M. LoRusso, DO, PhD (hc), FAACR, calls on the #AACR25 delegates to stand together and call on Congress to make cancer research a national priority.

To learn more about some of the new models we’ve developed to deconstruct benign-to-malignant transition, please check out the very talented Leonie Qin’s poster (# LB475), session 54 no. 12 Wed morning. Her thesis work has been integral to this project!

Addressing Tumor Heterogeneity: Personalized Cancer Vaccines— Catherine J. Wu addressed this topic to close out the Opening Plenary Session of the AACR Annual Meeting 2025. #AACR25

I had a wonderful time in the Tumor Microenvironment Working Group session! #AACR25 Thanks everyone for the warm welcome and lively discussion!

Out now in Cancer Discovery and featured #AACR25, we show a combinatorial approach to overcome resistance to RAS(ON) inhibitor monotherapy in PDAC, where use of CDK4/6 inhibitor Palbociclib and CD40 agonist drives therapy-induced senescence & CD4 T cell-dependent tumor-immune equilibrium

Today, the American Association for Cancer Research (AACR) called on Congress to reject the Administration's nearly 40% cut to the NIH budget and allocate a bipartisan funding increase to $51.3 billion for the agency to accelerate progress for patients. brnw.ch/21wSrQk

I am thrilled to share that the first preprint from my lab is now available on bioRxiV! In this study, our team elucidates the role of autocrine ligands in the aberrant behavior of oncogene-driven lung cancer. biorxiv.org/content/10.110…